Own how Avante creates pipeline by running cold outbound into enterprise HR and benefits leaders, qualifying inbound demand, and converting warm introductions from channel partners.
Compensation
The OTE for this role is $110,000-$130,000.
Responsibilities
Build an enterprise pipeline across three motions
Run cold outbound into Fortune 1000 HR and benefits leaders
Drive new software bookings from within existing customer base as a Senior Mid-Market Account Manager.
Locations (2)
United States
Canada
Compensation
The expected On-Target Earnings (OTE = base salary + variable) range for this position is between $117,150 and $184,350 (United States) or, $117,800 and $176,300 CAD (Canada), with variable earning opportunities uncapped.
Responsibilities
Serve as the primary sales point of contact for a portfolio of Mid-Market customers
Develop deep understanding of customer’s goals, pain points, and operational structure
Build multi-threaded relationships with champions, influencers, and senior executives
Identify and close opportunities to expand existing customer accounts
Sell new products, modules, user licenses, and platform solutions into current environments
Requirements
Bachelor’s Degree or Equivalent Experience in Business, Communications, or related field
Competitive compensation: 5000-6000 USD base per month + commissions
Responsibilities
Build a consistent pipeline of new opportunities through cold outbound across email, LinkedIn, calls, events, referrals, and creative prospecting channels
Research and map target accounts, identify the right entry points, and multi-thread across 3+ stakeholders
Own the full sales cycle from first outbound touch to closed-won, including discovery, business case development, negotiation, procurement, and contracting
Identify and develop internal champions, equipping them with the business case, ROI narrative, and materials they need to sell Nebius Academy internally
Navigate complex Enterprise buying processes by identifying champions, economic buyers, decision-makers, and potential blockers early in the cycle